Moderna’s coronavirus vaccine shows encouraging early results in human safety trial

Moderna’s announcement comes days after one of its directors, Moncef Slaoui, stepped down to become chief scientist for Operation Warp Speed, a White House initiative to speed up vaccine development. Watchdogs called out Slaoui’s apparent conflict of interest since he still owns stock options in Moderna worth $10 million.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news